U.S. federal trademark · Serial No. 50144563
Medical testing services for the early detection, diagnosis, monitoring, and prognosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing cancer screening services; medical testing services for minimal residual disease monitoring; medical testing services for tumor-of-origin determination; genetic and epigenetic testing for cancer risk for medical purposes; consulting services in the field of diagnostic medical testing; providing medical information in the field of cancer diagnosis and screening
Scientific and technological research in the field of genetics, epigenetics, and cancer biomarker identification; design and development of diagnostic testing methods, algorithms, and technology for the detection, monitoring, and prognosis of cancer
Diagnostic test kits for medical use comprised of reagents for detecting genetic and epigenetic biomarkers associated with cancer; diagnostic reagents for medical use for identifying and measuring genetic and epigenetic changes associated with cancer; medical diagnostic reagents and assays for testing of bodily fluids and tissue samples for use in cancer detection; diagnostic preparations for medical use for the detection of cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.